EC: 2.8.2.1
aryl sulfotransferase (3'-phosphoadenylyl-sulfate:phenol sulfotransferase)
Pathways
| pathway id | name |
|---|---|
| BioCyc:HUMAN_PWY66-401 | superpathway of tryptophan utilization |
| BioCyc:HUMAN_PWY-6402 | superpathway of melatonin degradation |
| BioCyc:META_PWY6666-2 | dopamine degradation |
| BioCyc:META_PWY-6313 | serotonin degradation |
| BioCyc:HUMAN_PWY-6398 | melatonin degradation I |
| BioCyc:META_PWY-6261 | thyroid hormone metabolism II (via conjugation and/or degradation) |
| BioCyc:HUMAN_PWY-6261 | thyroid hormone metabolism II (via conjugation and/or degradation) |
| BioCyc:HUMAN_PWY-6313 | serotonin degradation |
| BioCyc:META_PWY-6398 | melatonin degradation I |
| BioCyc:MOUSE_PWY6666-2 | dopamine degradation |
| BioCyc:HUMAN_PWY6666-2 | dopamine degradation |
| BioCyc:META_PWY-6402 | superpathway of melatonin degradation |
| Reactome:R-BTA-9748784 | Drug ADME |
| Reactome:R-CEL-9753281 | APAP ADME |
| Reactome:R-MMU-9753281 | APAP ADME |
| Reactome:R-RNO-9748784 | Drug ADME |
| Reactome:R-BTA-9753281 | APAP ADME |
| Reactome:R-CFA-9748784 | Drug ADME |
| Reactome:R-RNO-9753281 | APAP ADME |
| Reactome:R-CEL-9748784 | Drug ADME |
| Reactome:R-HSA-9753281 | APAP ADME |
| Reactome:R-MMU-9748784 | Drug ADME |
| Reactome:R-CFA-9753281 | APAP ADME |
| Reactome:R-HSA-9748784 | Drug ADME |
| Reactome:R-BTA-1430728 | Metabolism |
| Reactome:R-CEL-211859 | Biological oxidations |
| Reactome:R-CEL-156584 | Cytosolic sulfonation of small molecules |
| Reactome:R-CFA-1430728 | Metabolism |
| Reactome:R-CFA-156580 | Phase II - Conjugation of compounds |
| Reactome:R-HSA-211859 | Biological oxidations |
| Reactome:R-HSA-381070 | IRE1alpha activates chaperones |
| Reactome:R-MMU-1430728 | Metabolism |
| Reactome:R-MMU-211859 | Biological oxidations |
| Reactome:R-BTA-211859 | Biological oxidations |
| Reactome:R-CFA-156584 | Cytosolic sulfonation of small molecules |
| Reactome:R-HSA-156580 | Phase II - Conjugation of compounds |
| Reactome:R-HSA-2262752 | Cellular responses to stress |
| Reactome:R-MMU-156580 | Phase II - Conjugation of compounds |
| Reactome:R-RNO-211859 | Biological oxidations |
| Reactome:R-BTA-156584 | Cytosolic sulfonation of small molecules |
| Reactome:R-CEL-156580 | Phase II - Conjugation of compounds |
| Reactome:R-CFA-211859 | Biological oxidations |
| Reactome:R-HSA-381119 | Unfolded Protein Response (UPR) |
| Reactome:R-HSA-381038 | XBP1(S) activates chaperone genes |
| Reactome:R-RNO-1430728 | Metabolism |
| Reactome:R-RNO-156584 | Cytosolic sulfonation of small molecules |
| Reactome:R-BTA-156580 | Phase II - Conjugation of compounds |
| Reactome:R-CEL-1430728 | Metabolism |
| Reactome:R-HSA-1430728 | Metabolism |
| Reactome:R-HSA-156584 | Cytosolic sulfonation of small molecules |
| Reactome:R-HSA-8953897 | Cellular responses to stimuli |
| Reactome:R-MMU-156584 | Cytosolic sulfonation of small molecules |
| Reactome:R-RNO-156580 | Phase II - Conjugation of compounds |
| WikiPathways:WP5320 | Male steroid hormones in cardiomyocyte energy metabolism |
| PathBank:SMP0000041 | Sulfate/Sulfite Metabolism |
| PathBank:SMP0000532 | Sulfite Oxidase Deficiency |
| PathBank:SMP0000649 | Lamivudine Metabolism Pathway |
| PathBank:SMP0000640 | Acetaminophen Metabolism Pathway |
| PathBank:SMP0087489 | Androgen and Estrogen Metabolism |
| PathBank:SMP0000606 | Tamoxifen Metabolism Pathway |
| PathBank:SMP0087444 | Sulfate/Sulfite Metabolism |
| PathBank:SMP0087532 | Estrone Metabolism |
| PathBank:SMP0000471 | Tamoxifen Action Pathway |